08/21/2026
A new cancer vaccine developed by Moderna and Merck could change treatment options. Newsweek interviewed Dean Cathy Bradley, a career cancer researcher, about the potential economic implications for patients and their families. https://buff.ly/90fvjml
If ongoing studies in other cancers produce similar results, the technology could influence far more than cancer care itself.